Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 232

1.

FOXL2 is a sensitive and specific marker for sex cord-stromal tumors of the ovary.

Al-Agha OM, Huwait HF, Chow C, Yang W, Senz J, Kalloger SE, Huntsman DG, Young RH, Gilks CB.

Am J Surg Pathol. 2011 Apr;35(4):484-94. doi: 10.1097/PAS.0b013e31820a406c.

PMID:
21378549
2.

Ovarian sex cord-stromal tumors: an immunohistochemical study including a comparison of calretinin and inhibin.

Deavers MT, Malpica A, Liu J, Broaddus R, Silva EG.

Mod Pathol. 2003 Jun;16(6):584-90.

3.
4.

An immunohistochemical and molecular analysis of problematic and unclassified ovarian sex cord-stromal tumors.

Stewart CJ, Alexiadis M, Crook ML, Fuller PJ.

Hum Pathol. 2013 Dec;44(12):2774-81. doi: 10.1016/j.humpath.2013.07.028. Epub 2013 Oct 14.

PMID:
24134930
5.

CD10 expression in pure stromal and sex cord-stromal tumors of the ovary: an immunohistochemical analysis of 101 cases.

Oliva E, Garcia-Miralles N, Vu Q, Young RH.

Int J Gynecol Pathol. 2007 Oct;26(4):359-67.

PMID:
17885484
6.
8.

Identification of the most sensitive and robust immunohistochemical markers in different categories of ovarian sex cord-stromal tumors.

Zhao C, Vinh TN, McManus K, Dabbs D, Barner R, Vang R.

Am J Surg Pathol. 2009 Mar;33(3):354-66. doi: 10.1097/PAS.0b013e318188373d.

PMID:
19033865
9.

Inhibin expression in ovarian tumors and tumor-like lesions: an immunohistochemical study.

Kommoss F, Oliva E, Bhan AK, Young RH, Scully RE.

Mod Pathol. 1998 Jul;11(7):656-64.

PMID:
9688187
10.

Impact of a second opinion using expression and molecular analysis of FOXL2 for sex cord-stromal tumors. A study of the GINECO group & the TMRO network.

Maillet D, Goulvent T, Rimokh R, Vacher-Lavenu MC, Pautier P, Alexandre J, Pujade-Laurraine E, Devouassoux-Shisheboran M, Treilleux I, Ray-Coquard I, Savina A.

Gynecol Oncol. 2014 Jan;132(1):181-7. doi: 10.1016/j.ygyno.2013.10.013. Epub 2013 Oct 22.

PMID:
24157616
11.

CD56 is a sensitive and diagnostically useful immunohistochemical marker of ovarian sex cord-stromal tumors.

McCluggage WG, McKenna M, McBride HA.

Int J Gynecol Pathol. 2007 Jul;26(3):322-7.

PMID:
17581419
12.

Value of inhibin in the identification of granulosa cell tumors of the ovary.

Hildebrandt RH, Rouse RV, Longacre TA.

Hum Pathol. 1997 Dec;28(12):1387-95.

PMID:
9416696
13.

Ovarian steroid cell tumors: an immunohistochemical study including a comparison of calretinin with inhibin.

Deavers MT, Malpica A, Ordonez NG, Silva EG.

Int J Gynecol Pathol. 2003 Apr;22(2):162-7.

PMID:
12649671
14.

The FOXL2 mutation (c.402C>G) in adult-type ovarian granulosa cell tumors of three Japanese patients: clinical report and review of the literature.

Takahashi A, Kimura F, Yamanaka A, Takebayashi A, Kita N, Takahashi K, Murakami T.

Tohoku J Exp Med. 2013;231(4):243-50. Review.

15.

Expression of calretinin in human ovary, testis, and ovarian sex cord-stromal tumors.

Cao QJ, Jones JG, Li M.

Int J Gynecol Pathol. 2001 Oct;20(4):346-52.

PMID:
11603218
16.

Diagnostic utility of WT1 immunostaining in ovarian sertoli cell tumor.

Zhao C, Bratthauer GL, Barner R, Vang R.

Am J Surg Pathol. 2007 Sep;31(9):1378-86.

PMID:
17721194
17.

Mutation of FOXL2 in granulosa-cell tumors of the ovary.

Shah SP, Köbel M, Senz J, Morin RD, Clarke BA, Wiegand KC, Leung G, Zayed A, Mehl E, Kalloger SE, Sun M, Giuliany R, Yorida E, Jones S, Varhol R, Swenerton KD, Miller D, Clement PB, Crane C, Madore J, Provencher D, Leung P, DeFazio A, Khattra J, Turashvili G, Zhao Y, Zeng T, Glover JN, Vanderhyden B, Zhao C, Parkinson CA, Jimenez-Linan M, Bowtell DD, Mes-Masson AM, Brenton JD, Aparicio SA, Boyd N, Hirst M, Gilks CB, Marra M, Huntsman DG.

N Engl J Med. 2009 Jun 25;360(26):2719-29. doi: 10.1056/NEJMoa0902542. Epub 2009 Jun 10.

18.

A current perspective on the pathological assessment of FOXL2 in adult-type granulosa cell tumours of the ovary.

Kommoss S, Gilks CB, Penzel R, Herpel E, Mackenzie R, Huntsman D, Schirmacher P, Anglesio M, Schmidt D, Kommoss F.

Histopathology. 2014 Feb;64(3):380-8. doi: 10.1111/his.12253. Epub 2013 Nov 6.

PMID:
24192202
19.

Ovarian endometrioid carcinomas simulating sex cord-stromal tumors: a study using inhibin and cytokeratin 7.

Guerrieri C, Frånlund B, Malmström H, Boeryd B.

Int J Gynecol Pathol. 1998 Jul;17(3):266-71.

PMID:
9656124
20.

Inhibin immunohistochemistry applied to ovarian neoplasms: a novel, effective, diagnostic tool.

Costa MJ, Ames PF, Walls J, Roth LM.

Hum Pathol. 1997 Nov;28(11):1247-54.

PMID:
9385929

Supplemental Content

Support Center